General Information of Drug (ID: DM2NVLZ)

Drug Name
PMID25514969-Compound-8 Drug Info
Cross-matching ID
PubChem CID
118378988
TTD Drug ID
DM2NVLZ

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Patented Agent(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
TAK-935 DMOZAMN Dravet syndrome 8A61.11 Phase 2 [2]
PMID25514969-Compound-Figure3 DM7D12Y N. A. N. A. Patented [1]
PMID25514969-Compound-10 DME0XS4 N. A. N. A. Patented [1]
PMID25514969-Compound-9 DMAEZB1 N. A. N. A. Patented [1]
PMID25514969-Compound-Figure2-3 DMUYVOP N. A. N. A. Patented [1]
PMID25514969-Compound-11 DMUPL0W N. A. N. A. Patented [1]
PMID25514969-Compound-Figure2-4 DMXSAN7 N. A. N. A. Patented [1]
PMID25514969-Compound-13 DMQB03U N. A. N. A. Patented [1]
PMID25514969-Compound-12 DMOE5N0 N. A. N. A. Patented [1]
PMID25514969-Compound-Figure2-2 DMC6S0W N. A. N. A. Patented [1]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Cholesterol 24-hydroxylase (CYP46A1) TT4EB85 CP46A_HUMAN Inhibitor [1]

References

1 Imidazo[1,2-a]pyridines as cholesterol 24-hydroxylase (CYP46A1) inhibitors: a patent evaluation (WO2014061676).Expert Opin Ther Pat. 2015 Mar;25(3):373-7.
2 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800040983)